Thy and Ly markers on lymphocytes initiating tumor rejection.
D000818:Animals; D000941:Antigens; D000961:Antilymphocyte Serum / Q000494:pharmacology; D002471:Cell Transformation, Neoplastic; D003602:Cytotoxicity, Immunologic; D005260:Female; D005354:Fibrosarcoma / Q000276:immunology; D007106:Immune Sera / Q000494:pharmacology; D007165:Immunosuppression Therapy; D008214:Lymphocytes / Q000276:immunology*; D051379:Mice; D008808:Mice, Inbred CBA; D013601:T-Lymphocytes / Q000276:immunology
D000941:Antigens; D000961:Antilymphocyte Serum; D007106:Immune Sera